Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LYRIS 100/120 LABORATORY INFORMATION SYSTEM

K-Number: K923844 · 1992-12-11

ApplicantBiovation, Inc.
Decision Date1992-12-11
Product CodeJJQ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

LYRIS 100/120 LABORATORY INFORMATION SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Biovation, Inc.. It received FDA 510(k) clearance on 1992-12-11 under 510(k) number K923844. The device is classified under product code JJQ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LYRIS 100/120 LABORATORY INFORMATION SYSTEM?

LYRIS 100/120 LABORATORY INFORMATION SYSTEM is a medical device that received FDA 510(k) clearance on 1992-12-11. The listed applicant is Biovation, Inc.. The 510(k) number is K923844.

When did LYRIS 100/120 LABORATORY INFORMATION SYSTEM receive FDA 510(k) clearance?

LYRIS 100/120 LABORATORY INFORMATION SYSTEM received FDA 510(k) clearance on 1992-12-11, under 510(k) number K923844.

Who is the listed applicant for LYRIS 100/120 LABORATORY INFORMATION SYSTEM?

The FDA 510(k) record lists Biovation, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LYRIS 100/120 LABORATORY INFORMATION SYSTEM?

The FDA product code for LYRIS 100/120 LABORATORY INFORMATION SYSTEM is JJQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Biovation, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K925528BIOVATION K-MANAGERK915071DIFFERENTIAL COUNTING BOARDK853026BIOVATION MAX DATA MANAGEMENT SYSTEMK842401CHEMISTRY CONSOLEK831830LYRIS MODULAR INFO SYSTEMK821534HEMATOLOGY DATA MANAGEMENT SYS

View all 11 devices →

Related Devices (Code: JJQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K013371UBIT-IR300 INFRARED SPECTROMETRY SYSTEMOtsuka Pharmaceutical Co., Ltd.K980120DIGENE DML 2000 MICROPLATE LUMINOMETERDigene Corp.K973938ALPHA 4 LS AUTOMATED MICROTITERPLATE PROCESSOR AND READERSfri, Inc.K974762STAT TRACKSAwareness Technology, Inc.K962113ANTHOS PHACTS VERSION MICROPLATE READERColumbia Bioscience, Inc.K961183CBI 7520 READERColumbia Bioscience, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑